Annual report pursuant to Section 13 and 15(d)

ACQUISITIONS - Dynamic Advances, IP Liquidity and Sarif Biomedical (Details)

v3.7.0.1
ACQUISITIONS - Dynamic Advances, IP Liquidity and Sarif Biomedical (Details) - Dynamic Advances, IP Liquidity and Sarif Biomedical
Nov. 02, 2014
May 02, 2014
USD ($)
Pay Proceeds Agreement Member | Maximum    
Acquisitions    
Recovery of licensing or enforcement activities on patents   $ 250,000,000
Pay Proceeds Agreement Member | $10,000,000 or less | Maximum    
Acquisitions    
Recovery of licensing or enforcement activities on patents   $ 10,000,000
Pay Proceeds Agreement Member | $10,000,000 to $40,000,000    
Acquisitions    
Net recovery proceeds due to sellers (as a percent)   40.00%
Pay Proceeds Agreement Member | $10,000,000 to $40,000,000 | Minimum    
Acquisitions    
Recovery of licensing or enforcement activities on patents   $ 10,000,000
Pay Proceeds Agreement Member | $10,000,000 to $40,000,000 | Maximum    
Acquisitions    
Recovery of licensing or enforcement activities on patents   $ 40,000,000
Pay Proceeds Agreement Member | Over $40,000,000    
Acquisitions    
Net recovery proceeds due to sellers (as a percent)   50.00%
Pay Proceeds Agreement Member | Over $40,000,000 | Minimum    
Acquisitions    
Recovery of licensing or enforcement activities on patents   $ 40,000,000
Registration Rights Agreement Member | Maximum    
Acquisitions    
Registration statements required to be filed (in statements) 3  
Filing period 60 days  
Series B Convertible Preferred Stock | Registration Rights Agreement Member | Minimum    
Acquisitions    
Percentage of registrable shares covered in resale registration statement (as a percent) 10.00%